|Grant Affiliation:||McElrath: Innate to Adaptive Immunity|
|Strategy:||Protein & peptide vaccines|
|Study Type:||Pre-Clinical NHP|
|Study Start Date:||2012-03-09|
|Study Made Public:||2016-10-21|
Evaluating the impact in nonhuman primates of using nano particle formulated TLR 4 and 7 agonists for enhancing humoral immunity against HIV specific envelope protein immunogens - a study conducted by the Pulandran laboratory
CAVD 355 (CAVIMC-045) is a non-human primate study of protein and adjuvant regimens.
Sign in to see full information about this study and to download study data.